Compare KRYS & CBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KRYS | CBC |
|---|---|---|
| Founded | 2015 | 1902 |
| Country | United States | United States |
| Employees | 295 | 3036 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 6.4B |
| IPO Year | 2017 | N/A |
| Metric | KRYS | CBC |
|---|---|---|
| Price | $340.21 | $28.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | ★ $297.60 | $28.67 |
| AVG Volume (30 Days) | 294.7K | ★ 827.3K |
| Earning Date | 05-04-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 2.21% |
| EPS Growth | ★ 128.00 | N/A |
| EPS | ★ 1.83 | N/A |
| Revenue | ★ $389,130,000.00 | N/A |
| Revenue This Year | $38.74 | $12.15 |
| Revenue Next Year | $32.53 | $6.34 |
| P/E Ratio | $187.67 | ★ $14.38 |
| Revenue Growth | ★ 33.94 | N/A |
| 52 Week Low | $130.50 | $22.50 |
| 52 Week High | $356.50 | $29.26 |
| Indicator | KRYS | CBC |
|---|---|---|
| Relative Strength Index (RSI) | 65.25 | 58.42 |
| Support Level | $253.89 | $23.28 |
| Resistance Level | N/A | $29.17 |
| Average True Range (ATR) | 12.77 | 0.89 |
| MACD | 2.68 | -0.06 |
| Stochastic Oscillator | 72.67 | 80.32 |
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
Central Bancompany Inc is a bank holding company that provides a broad range of retail, corporate, mortgage banking, wealth management, and trust products and services to individuals and businesses. Its operating segments include Consumer, Commercial, and Wealth Management. The company generates the majority of its revenue from the Commercial segment, which provides full-service relationship banking solutions to businesses, agencies, and community organizations, including commercial, small business, and government clients. The segment also offers business payment solutions such as treasury management services, merchant services, and commercial bank card products.